Richell Booijink
Overview
Explore the profile of Richell Booijink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lori G, Pastore M, Navari N, Piombanti B, Booijink R, Rovida E, et al.
JHEP Rep
. 2024 Oct;
6(10):101182.
PMID: 39430578
Background & Aims: Among the reprogrammed metabolic pathways described in cancer stem cells, aberrant lipid metabolism has recently drawn increasing attention. Our study explored the contribution of fatty acids (FA)...
2.
Ten Hove M, Smyris A, Booijink R, Wachsmuth L, Hansen U, Alic L, et al.
Bioact Mater
. 2024 Jun;
39:406-426.
PMID: 38855059
Endothelin-1/endothelin A receptor (ET-1/ETAR) pathway plays an important role in the progression of liver fibrosis by activating hepatic stellate cells (HSCs) - a key cell type involved in the pathogenesis...
3.
Booijink R, Ramachandran P, Bansal R
Trends Pharmacol Sci
. 2024 Jun;
45(7):614-627.
PMID: 38853100
Growing evidence suggests that metabolic dysfunction-associated steatotic liver disease (MASLD) is significantly higher in men versus women. Increased prevalence is observed in postmenopausal women, suggesting that age and sex (hormones)...
4.
Booijink R, Terstappen L, Dathathri E, Isebia K, Kraan J, Martens J, et al.
Mol Oncol
. 2024 Apr;
PMID: 38634185
In prostate cancer (PCa), cancer-associated fibroblasts (CAFs) promote tumor progression, drug resistance, and metastasis. Although circulating tumor cells are studied as prognostic and diagnostic markers, little is known about other...
5.
Booijink R, Terstappen L, Bansal R
Methods Mol Biol
. 2023 May;
2669:257-268.
PMID: 37247066
Activated hepatic stellate cells (HSCs) that secrete large amounts of extracellular matrix (ECM) proteins, primarily collagens, are recognized as the key pathogenic cells in liver diseases. Excessive ECM accumulation results...
6.
Booijink R, Salgado-Polo F, Jamieson C, Perrakis A, Bansal R
EMBO Mol Med
. 2022 Jul;
14(9):e16333.
PMID: 35833384
The lysophosphatidic acid (LPA) signaling axis is an important but rather underexplored pathway in liver disease. LPA is predominantly produced by Autotaxin (ATX) that has gained significant attention with an...
7.
Heinrich L, Booijink R, Khurana A, Weiskirchen R, Bansal R
Trends Pharmacol Sci
. 2021 Dec;
43(3):188-205.
PMID: 34961619
Chronic liver diseases (CLDs) caused by viral infections, alcohol/drug abuse, or metabolic disorders affect millions of people globally and have increased mortality owing to the lack of approved therapies. Lipoxygenases...
8.
Geervliet E, Moreno S, Baiamonte L, Booijink R, Boye S, Wang P, et al.
J Control Release
. 2021 Mar;
332:594-607.
PMID: 33737203
Liver fibrosis affects millions of people worldwide and is rising vastly over the past decades. With no viable therapies available, liver transplantation is the only curative treatment for advanced diseased...
9.
Kurniawan D, Booijink R, Pater L, Wols I, Vrynas A, Storm G, et al.
J Control Release
. 2020 Sep;
328:640-652.
PMID: 32979454
Liver diseases are the growing health problem with no clinically approved therapy available. Activated hepatic stellate cells (HSCs) are the key driver cells responsible for extracellular matrix deposition, the hallmark...
10.
Francis K, Booijink R, Bansal R, Steenbergen W
Sensors (Basel)
. 2020 May;
20(10).
PMID: 32422995
Small animals are widely used as disease models in medical research. Noninvasive imaging modalities with functional capability play an important role in studying the disease state and treatment progress. Photoacoustics,...